股本结构
单位：万股
| 公告日期 | 2024-04-12 | 2024-03-15 | 2024-02-14 | 2024-03-28 | 2023-11-13 | 2023-08-10 |
|---|---|---|---|---|---|---|
| 证券总股本 | 99.45 | 9945.29 | 9945.29 | 2802.43 | 2567.83 | 2574.63 |
| 普通股本 | 99.45 | 9945.29 | 9945.29 | 2802.43 | 2567.83 | 2574.63 |
| 优先股 | 未披露 | 13.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2024-04-17 | 2024-03-04 | 2024-02-15 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2024-04-12 | 99.45 | 未披露 | 定期报告 | 2024-04-17 |
| 2024-03-15 | 9945.29 | 13.00 | 定期报告 | 2024-03-04 |
| 2024-02-14 | 9945.29 | 1.00 |
更多>>
Units offered 71,428,571 shares by the company
|
2024-02-15 |
| 2024-03-28 | 2802.43 | 1.00 |
更多>>
From December 31, 2022 to December 31, 2023
Repurchase of treasury stock
Exercise of warrants
Common stock and pre-funded warrants issued in a private offering net of expenses
|
2023-12-31 |
| 2023-11-13 | 2567.83 | 1.00 |
更多>>
From June 30, 2023 to September 30, 2023
Repurchase stock
|
2023-09-30 |
| 2023-08-10 | 2574.63 | 1.00 |
更多>>
From March 31, 2023 to June 30, 2023
Common stock and pre-funded warrants issued in a private offering
Exercise of warrants
|
2023-06-30 |
| 2023-05-25 | 2458.99 | 未披露 | 定期报告 | 2023-05-23 |
| 2023-05-10 | 2213.99 | 1.00 |
更多>>
From December 31, 2022 to March 31, 2023
Repurchased stock
|
2023-03-31 |
| 2023-04-04 | 2258.56 | 1.00 |
更多>>
From December 31, 2021 to December 31, 2022
Common stock and warrants issued in offerings
Fractional shares issued for reverse stock split
Exercise of warrants
Common stock issued as part of Nora Pharma Inc. acquisition
|
2022-12-31 |
| 2022-11-07 | 2258.56 | 未披露 | 定期报告 | 2022-11-07 |
| 2022-08-03 | 1888.56 | 1.00 |
更多>>
From March 31, 2022 to June 30, 2022
Common stock and pre-funded warrants issued in an underwritten public offering, net of issuance costs
Exercise of warrants
|
2022-06-30 |
| 2022-05-20 | 1649.56 | 未披露 | 定期报告 | 2022-04-29 |
| 2022-05-06 | 714.98 | 1.00 |
更多>>
From December 31, 2021 to March 31, 2022
Common stock and pre-funded warrants issued in an underwritten public offering, net of issuance costs
Exercise of warrants
|
2022-03-31 |
| 2022-03-21 | 712.98 | 未披露 | 定期报告 | 2022-03-16 |
| 2022-03-15 | 677.49 | 未披露 | 定期报告 | 2022-03-10 |
| 2022-02-17 | 447.36 | 未披露 | 定期报告 | 2022-02-15 |
| 2022-03-21 | 259.12 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Common stock issued for reduction of debt and interest
Common stock issued for services
|
2021-12-31 |
Units offered 71,428,571 shares by the company
From December 31, 2022 to December 31, 2023
Repurchase of treasury stock
Exercise of warrants
Common stock and pre-funded warrants issued in a private offering net of expenses
From June 30, 2023 to September 30, 2023
Repurchase stock
From March 31, 2023 to June 30, 2023
Common stock and pre-funded warrants issued in a private offering
Exercise of warrants
From December 31, 2022 to March 31, 2023
Repurchased stock
From December 31, 2021 to December 31, 2022
Common stock and warrants issued in offerings
Fractional shares issued for reverse stock split
Exercise of warrants
Common stock issued as part of Nora Pharma Inc. acquisition
From March 31, 2022 to June 30, 2022
Common stock and pre-funded warrants issued in an underwritten public offering, net of issuance costs
Exercise of warrants
From December 31, 2021 to March 31, 2022
Common stock and pre-funded warrants issued in an underwritten public offering, net of issuance costs
Exercise of warrants
From December 31, 2020 to December 31, 2021
Common stock issued for reduction of debt and interest
Common stock issued for services